RhumbLine Advisers
CPXX

RhumbLine Advisers’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

RhumbLine Advisers’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-33,659
Closed -$1.02M – 2990
2016
Q2 		$1.02M Buy
+33,659
New +$683K ﹤0.01% 1773

RhumbLine Advisers's CPXX Position: Q3 2016 in Review

RhumbLine Advisers sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 33,659 shares — an estimated $1.02M sold.

RhumbLine Advisers first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $1.02M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • RhumbLine Advisers reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • RhumbLine Advisers sold 33,659 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $1.02M.
  • RhumbLine Advisers first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • RhumbLine Advisers's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $1.02M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on RhumbLine Advisers's 13F filing for Q3 2016, filed 8 Nov 2016.